28
Views
2
CrossRef citations to date
0
Altmetric
Papers

Association between apolipoprotein E4 genotype and human immunodeficiency virus–associated dementia in younger adults starting antiretroviral therapy in South Africa

, , , , , , & show all
Pages 377-383 | Received 02 Jun 2010, Accepted 29 Jul 2010, Published online: 08 Sep 2010
 

Abstract

It is not known whether the apolipoprotein E (ApoE) ε4 allelic variant is associated with human immunodeficiency virus (HIV)-associated dementia (HAD) in a South African population, where HIV clade C is predominant. ApoE genotyping was performed on 144 participants in a larger study of HIV-associated neurocognitive disorders (HAND). There was a lower frequency of the ε2 and ε3 alleles in the HIV-positive group, compared to a group of 300 community-based newborn infants. There were no differences in ApoE genotype across different categories of HAND. The ε4 allelic variant was less common in individuals with HAD than in those without HAD. These findings suggest that the ε4 allelic variant in HIV-positive individuals is not associated with the development of HAD in Southern Africa.

Acknowledgements

The authors wish to acknowledge and note the work of Alan J. Flisher (AJF) in this work. He passed away in April 2010 after a short battle with leukaemia and will be sorely missed.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.